Fate Therapeutics (FATE) EBITDA Margin (2012 - 2026)
Fate Therapeutics (FATE) posted EBITDA Margin of -1361.86% for Q2 2026, up 404.79 percentage points from -1766.65% a year earlier and up 953.92 percentage points from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) EBITDA Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Fate Therapeutics was -1873.39%, up 208.12 percentage points year-over-year; for FY2025, it was -2028.33%, down 625.09 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -1640.62 percentage points (FY2020 to FY2025).
- In prior years, Fate Therapeutics' EBITDA Margin was -1403.24% in FY2024 (-1143.51 pp), -259.73% in FY2023 (+43.39 pp), -303.13% in FY2022 (+67.71 pp) and -370.84% in FY2021 (+16.88 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin since Q2 2024.
- On a year-over-year basis, EBITDA Margin has increased in each of the last three quarters, with an average year-over-year change of +21.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2024, with a gain of 5631.10 percentage points; the weakest was Q2 2023, with a drop of 5793.25 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -2315.78% (Q1 2026), -2312.49% (Q4 2025) and -1809.76% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,361.86% |
| Mar 31, 2026 | -2,315.78% |
| Dec 31, 2025 | -2,312.49% |
| Sep 30, 2025 | -1,809.76% |
| Jun 30, 2025 | -1,766.65% |
| Mar 31, 2025 | -2,329.47% |
| Dec 31, 2024 | -3,058.98% |
| Sep 30, 2024 | -1,554.00% |
| Jun 30, 2024 | -596.01% |
| Mar 31, 2024 | -2,402.44% |
| Dec 31, 2023 | -2,575.89% |
| Sep 30, 2023 | -2,393.98% |
| Jun 30, 2023 | -6,227.12% |
| Mar 31, 2023 | -29.17% |
| Dec 31, 2022 | -131.67% |
| Sep 30, 2022 | -550.13% |
| Jun 30, 2022 | -433.87% |
| Mar 31, 2022 | -383.47% |
| Dec 31, 2021 | -385.72% |
| Sep 30, 2021 | -365.54% |
API Access
Fate Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();